These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 19104424

  • 21. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
    Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J.
    Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
    [Abstract] [Full Text] [Related]

  • 22. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL, Regev A, Casanova-Romero PY, Bejarano PA, Martinez EJ, Tzakis AG, Schiff ER.
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [Abstract] [Full Text] [Related]

  • 23. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study.
    McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR, Vargas H, Donovan J, Trotter J, Faust T.
    Liver Transpl; 2007 Sep; 13(9):1246-53. PubMed ID: 17763405
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis C infection and survivals of liver transplant patients in Canada, 1997-2003.
    Hong Z, Smart G, Dawood M, Kaita K, Wen SW, Gomes J, Wu J.
    Transplant Proc; 2008 Jun; 40(5):1466-70. PubMed ID: 18589130
    [Abstract] [Full Text] [Related]

  • 25. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
    Villamil F, Levy G, Grazi GL, Mies S, Samuel D, Sanjuan F, Rossi M, Lake J, Munn S, Mühlbacher F, Leonardi L, Cillo U.
    Transplant Proc; 2006 Nov; 38(9):2964-7. PubMed ID: 17112875
    [Abstract] [Full Text] [Related]

  • 26. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients.
    Pérez-Daga JA, Ramírez-Plaza C, Suárez MA, Santoyo J, Fernández-Aguilar JL, Aranda JM, Sánchez-Pérez B, González-Sánchez A, Alvárez A, Valle M, Bondía JA.
    Transplant Proc; 2008 Nov; 40(9):2959-61. PubMed ID: 19010159
    [Abstract] [Full Text] [Related]

  • 27. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
    Doyle MB, Anderson CD, Vachharajani N, Lowell JA, Shenoy S, Lisker-Melman M, Korenblat K, Crippin JS, Chapman WC.
    Arch Surg; 2008 Jul; 143(7):679-85; discussion 685. PubMed ID: 18645111
    [Abstract] [Full Text] [Related]

  • 28. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
    Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Romano J, Bozorgzadeh A.
    Transplant Proc; 2005 Sep; 37(7):3159-61. PubMed ID: 16213336
    [Abstract] [Full Text] [Related]

  • 29. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.
    Boin IF, Ataide EC, Leonardi MI, Stucchi R, Sevá-Pereira T, Pereira IW, Cardoso AR, Caruy CA, Luzo A, Leonardi LS.
    Transplant Proc; 2008 Apr; 40(3):792-6. PubMed ID: 18455019
    [Abstract] [Full Text] [Related]

  • 30. Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome.
    Nudo CG, Cortes RA, Weppler D, Schiff ER, Tzakis AG, Regev A.
    Transplant Proc; 2008 Jun; 40(5):1449-55. PubMed ID: 18589127
    [Abstract] [Full Text] [Related]

  • 31. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 32. Liver transplantation for hepatitis C.
    Marubashi S, Dono K, Miyamoto A, Takeda Y, Nagano H, Umeshita K, Monden M.
    J Hepatobiliary Pancreat Surg; 2006 Jan; 13(5):382-92. PubMed ID: 17013711
    [Abstract] [Full Text] [Related]

  • 33. Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation.
    Kohli V, Singhal A, Elliott L, Jalil S.
    Transpl Int; 2012 Feb; 25(2):192-200. PubMed ID: 22151471
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 35. Relapse response to interferon and ribavirin in liver transplant recipient with hepatitis C recurrence.
    Coccoli P, Cordone G, Bruno M, Parrilli G.
    Transplant Proc; 2005 Dec; 37(10):4406-7. PubMed ID: 16387132
    [Abstract] [Full Text] [Related]

  • 36. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I, Gruttadauria S, Nadalin S, Viganò J, di Francesco F, Pietrosi G, Fili' D, Montalbano M, D'Antoni A, Volpes R, Arcadipane A, Vizzini G, Gridelli B.
    Transplant Proc; 2008 Dec; 40(6):1976-8. PubMed ID: 18675105
    [Abstract] [Full Text] [Related]

  • 37. The natural history of hepatitis C virus in pediatric liver transplant recipients.
    Barshes NR, Udell IW, Lee TC, O'Mahony CA, Karpen SJ, Carter BA, Goss JA.
    Liver Transpl; 2006 Jul; 12(7):1119-23. PubMed ID: 16799942
    [Abstract] [Full Text] [Related]

  • 38. Donor-specific hyporesponsiveness in ELISPOT assay is associated with early recurrence of hepatitis C in liver transplant recipients.
    Tambur AR, Ben-Ari Z, Herrera ND, Klein T, Michowiz R, Mor E.
    Hum Immunol; 2005 Jan; 66(1):21-7. PubMed ID: 15620458
    [Abstract] [Full Text] [Related]

  • 39. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.
    Kamar N, Borde JS, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssière L, Durand D, Izopet J, Rostaing L.
    Clin Transplant; 2005 Feb; 19(1):83-9. PubMed ID: 15659139
    [Abstract] [Full Text] [Related]

  • 40. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.